Haisco(002653.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Haisco
002653.SZ
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd.
2.805 T
002653.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
PharmaceuticalsIndustry
Industry Ranking5/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE17.13%A
    • Profit Margin15.17%A
    • Gross Margin81.40%A
  • Growth ScoreA
    • Revenue YoY31.04%A
    • Net Profit YoY119.24%A
    • Total Assets YoY10.61%B
    • Net Assets YoY17.71%A
  • Cash ScoreB
    • Cash Flow Margin145.41%B
    • OCF YoY31.04%A
  • Operating ScoreB
    • Turnover0.69B
  • Debt ScoreB
    • Gearing Ratio36.78%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    New Drug Pricing Policy Empowers Innovation; Overseas Licensing Accelerates Dual-Drive Mechanism for the Industry

    Wallstreetcn·
    US
    ABBV
    +2.08%
    SZ
    002653
    +0.91%
    SH
    520880
    -1.12%
    Wallstreetcn·
    US
    ABBV
    +2.08%
    SZ
    002653
    +0.91%
    SH
    520880
    -1.12%

    AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid

    Pharmaceutical Technology·
    US
    ABBV
    +2.08%
    SZ
    002653
    +0.91%
    SZ
    159859
    -0.55%
    Pharmaceutical Technology·
    US
    ABBV
    +2.08%
    SZ
    002653
    +0.91%
    SZ
    159859
    -0.55%

    Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain | ABBV Stock News

    StockTitan·
    US
    LABU
    -2.35%
    SZ
    159859
    -0.55%
    US
    IXJ
    +0.79%
    StockTitan·
    US
    LABU
    -2.35%
    SZ
    159859
    -0.55%
    US
    IXJ
    +0.79%

    Haisco grants AirNexis global rights to HSK39004 drug in deal exceeding USD 1 billion, targeting COPD market.

    Unusual Whales·
    SZ
    002653
    +0.91%
    Unusual Whales·
    SZ
    002653
    +0.91%

    China's Haisco Licenses COPD Drug to AirNexis for Up to USD1.1 Billion

    Yicai·
    SZ
    002653
    +0.91%
    Yicai·
    SZ
    002653
    +0.91%
    © 2026 Longbridge｜Disclaimer